ASCO 2018 Multiple Myeloma eAbstracts
"E-abstracts" for the 2018 American Society of Clinical Oncology (ASCO) annual meeting are abstracts that have been accepted for publication with all other abstracts from the meeting, but will not be summarized in-person by the researchers in either an oral or poster presentation.
The list below contains the titles and authors of all ASCO 2018 multiple myeloma e-abstracts. Each entry in the list also includes a link to the full text of the relevant abstract at the ASCO website.
The Beacon also has similar lists of ASCO 2018 multiple myeloma-related oral presentations, poster presentations, and education session presentations as well as news articles about multiple myeloma at the ASCO 2018 meeting.
e20001 - Platelet count and transfusion dependence as prognostic factors of engraftment in autologous stem cell transplantation
Forat Lutfi, William Paul Skelton, Yu Wang, Emma Rosenau, Hemant S. Murthy, Randy Brown, John R. Wingard, Maxim Norkin (abstract)
e20002 - Effects of a temporal break between mobilization and conditioning on complications and hospitalization charges in multiple myeloma patients undergoing autologous stem cell transplant (ASCT)
Jayadev Manikkam Umakanthan, Austin Barry, Valerie Shostrom, Deborah Swanson, Kimberly Schmit-Pokorny, Dawn Jourdan, Muhamed Baljevic, Sarah A. Holstein, Gregory Bociek, Julie Vose, Matthew Alexander Lunning (abstract)
e20003 - Infectious complications in multiple myeloma (MM) patients receiving autologous hematopoietic cell transplantation (AutoHCT) in the contemporary era
Shafia Rahman, Lisa A. Rybicki, Sherif B Mossad, Ronald M. Sobecks, Navneet S. Majhail (abstract)
e20004 - Relationship between disease activity and circulating endothelial and endothelial progenitor cells in multiple myeloma
Patrick Alan Hagen, William Adams, Stephanie Bochen Tsai, Scott E. Smith, Patricia Patrick Simms, Patrick J. Stiff (abstract)
e20005 - Risks of upper respiratory tract infection and pneumonia in patients with multiple myeloma receiving Daratumumab: A systematic review and meta-analysis of randomized controlled trials
Katy Ticona, Aung Tun, Elizabeth Guevara (abstract)
e20006 - An evaluation of c-myc aberrations in patients with newly diagnosed multiple myeloma (NDMM)
Amy Guzdar, Caitlin Costello (abstract)
e20007 - Effect of renal impairment (RI) on intravenous bisphosphonates (IVBP) and multiple myeloma (MM) treatment
Debajyoti Bhowmik, Ningqi Hou, Laura Kauffman, Sam Colman, Sarah Vidito, Michele Intorcia (abstract)
e20008 - Adherence to pomalidomide in patients with multiple myeloma: A US-based claims study
Justin Gatwood, Ankur Dashputre, Katie S Gatwood (abstract)
e20009 - Impact of skeletal-related events on multiple myeloma treatment
Debajyoti Bhowmik, Nianwen Shi, Janna Manjelievskaia, Xue Song, Sarah Vidito, Michele Intorcia (abstract)
e20010 - Impact of adherence to pomalidomide on medication adherence in pre-existing chronic conditions in patients with multiple myeloma
Justin Gatwood, Ankur Dashputre, Katie S Gatwood (abstract)
e20011 - Time to deterioration (TTD) in health-related quality of life (HRQoL) with carfilzomib plus dexamethasone (Kd56) versus bortezomib plus dexamethasone (Vd) in the ENDEAVOR trial
Katja Weisel, Heinz Ludwig, Meletios A. Dimopoulos, Martin Kaiser, Roman Hajek, Joseph Mikhael, Kim Cocks, Sumeet Panjabi (abstract)
e20012 - Efficacy and safety of pomalidomide as a replacement therapy for lenalidomide for relapsed/refractory multiple myeloma patients refractory to a lenalidomide-containing combination regimen
James R. Berenson, Alexa Cohen, Tanya M. Spektor, Ashkan Lashkari, Roy Mackintosh, Alberto Bessudo, Michael Oren Robinson, Haresh S. Jhangiani, Nashat Y. Gabrail, Ibrahim Nakhoul, Samir V. Kubba, Jeffrey D. Neidhart, Tina Maluso, Regina A. Swift, Robert A. Vescio (abstract)
e20015 - Trends of hospitalization for multiple myeloma patients: Insights from the national inpatient sample database
Anusha Vakiti, Bhavisha Patel, Anil Jonnalagadda, Muhamad Alhaj Moustafa, Facundo Stingo, Prerna Mewawalla, Aarthi G. Shenoy (abstract)
e20016 - Emerging immunotherapy and decade of early phase drug development: Systematic review of multiple myeloma treatment
Warda Faridi, Shaunak Pandya, Ceren Durer, Seren Durer, Mitchell Ross, Saad Malik, Arveen Saeideh Asghar, Atif Sohail, Sabina Saeed, Pavan Tenneti, Muhammad Sardar, Aparna Nallagangula, Hani M. Babiker, Faiz Anwer (abstract)
e20017 - Natural history of delp53 multiple myeloma
Arjun Lakshman, Utkarsh Painuly, S. Vincent Rajkumar, Angela Dispenzieri, Morie A Gertz, Francis Buadi, Martha Lacy, David Dingli, Suzanne R. Hayman, Taxiarchis Kourelis, Rahma M. Warsame, Wilson I. Gonsalves, Prashant Kapoor, Nelson Leung, Ronald S. Go, John Anthony Lust, Stephen J. Russell, Steven R. Zeldenrust, Robert A. Kyle, Shaji Kumar (abstract)
e20019 - Real-world utilization of multiple myeloma treatments in the era of novel therapies: What is the current standard of care?
David Singer, Ellen Thiel, Debra E. Irwin, Meghan Moynihan, Caroline McKay, Eric Maiese (abstract)
e20020 - Can bortezomib combined chemotherapy be helpful for even elderly unfit patients with newly diagnosed multiple myeloma
Ho Sup Lee, Da Jung Kim, Lee Chun Park, Je-Jung Lee, Sung-Hoon Jung, Jae-Cheol Jo, Ji Hyun Lee, Su-Hee Cho, Young Kwang Chae (abstract)
e20021 - Incidence and risks of pneumonia in patients with multiple myeloma treated with daratumumab: A systematic review and meta-analysis of randomized controlled trials
Aung Tun, Katy Ticona, Kyaw Zin Thein, Poras Patel, Vadim Zarubin, Elizabeth Guevara (abstract)
e20022 - Drivers of phase-based costs in patients with multiple myeloma
Abdalla Aly, Zoe Clancy, Brian Ung, Amit Agarwal, Ruchit Shah (abstract)
e20023 - Global burden of multiple myeloma: A systematic analysis for the Global Burden of Disease study 2016
Andrew Cowan, Edward N. Libby, Christina Fitzmaurice (abstract)
e20024 - Impact of baseline renal function on efficacy and safety of daratumumab plus bortezomib-melphalan-prednisone (VMP) in patients (Pts) with newly diagnosed multiple myeloma (NDMM) ineligible for transplantation (ALCYONE)
Michele Cavo, Meletios A. Dimopoulos, Jesus San-Miguel, Andrzej J. Jakubowiak, Kenshi Suzuki, Sung-Soo Yoon, Mark Cook, Mario Boccadoro, P. Joy Ho, Ludek Pour, Stefan Knop, Chantal Doyen, Tamas Masszi, Joan Blade, Jianping Wang, Susan Wroblewski, William Deraedt, Ming Qi, Maria-Victoria Mateos (abstract)
e20025 - Characterization of resistance to APO010, a recombinant hexameric FAS ligand, in human myeloma cell lines
Haatisha Jandu, Annette Nielsen, Nils Brunner, Anker Hansen, Steen Knudsen, Peter Buhl Jensen (abstract)
e20026 - Outcome of multiple myeloma patients with renal failure: A retrospective study
Ramavath Devendra Naik, Lalit Kumar, Abhenil Mittal, Vineet Govinda Gupta, Mukesh Patekar, Prabhat Singh Malik, Santosh Kumar, Vishwajeet Singh (abstract)
e20027 - Oxidative processes in the blood during chemotherapy and lethality of patients with multiple myeloma
Irina A. Goroshinskaya, Oleg I. Kit, Natalia Zuderman, Nadezhda D. Ushakova, Irina B. Lysenko, Ludmila A. Nemashkalova, Nadezhda V. Nikolaeva, Elena A. Kapuza, Olga N. Shatokhina (abstract)
e20028 - Outcomes of spinal stabilization in multiple myeloma with unstable vertebral lesions background
Tara Rajendran, Ishwara Keerthi (abstract)
e20030 - Novel treatment (Tx) use and associated outcomes among African American patients (pts) with multiple myeloma (MM): A SEER-Medicare analysis
Kejal Parikh, Zoe Clancy, Zheng-Yi Zhou, Wenxi Tang, Claudia Cheung, Zhou Zhou, Jipan Xie, Sikander Ailawadhi (abstract)
e20031 - Factors associated with non-adherence to lenalidomide in patients with multiple myeloma
Siyang Leng, Suzanne Lentzsch, Yizhen Chen, Melissa Kate Accordino, Jason Dennis Wright, Alfred I. Neugut, Dawn L. Hershman (abstract)
e20033 - Prospective evaluation of minimal residual disease in multiple myeloma following autologous stem cell transplantation(ASCT) and consolidation therapy
Siyang Leng, Suzanne Lentzsch, Yizhen Chen, Melissa Kate Accordino, Jason Dennis Wright, Alfred I. Neugut, Dawn L. HershmanMukesh Patekar, Lalit Kumar, Atul Sharma, Ritu Gupta, Sreenivas Vishnubhatla, Ramavath Devendra Naik, Rohit Ramesh Pai, Akash Tiwari, Meetu Dahiya (abstract)
e20035 - Large retrospective study of lenalidome-dexamethasone (Rd) in patients older than 80 with multiple myeloma (MM): Is less more?
Magalie Pascale Tardy, Borhane Slama, Jerome Doyen, Anne-Marie Stoppa, Jean Gutnecht, Daniel Re, Valentine Richez, Regis Kaphan, Maria Kogay, Marie-Christine Etienne-Grimaldi, Annick Boscagli, Frederic Peyrade (abstract)
e20036 - Effect of anticoagulation choice on survival for patients with myeloma being treated with a proteasome inhibitor
Dianne Pulte, Nicole Gormley, Ann T. Farrell (abstract)
e20037 - Cost per median month of progression-free survival for daratumumab plus bortezomib and dexamethasone compared with carfilzomib plus dexamethasone in relapsed/refractory multiple myeloma
Eric Maiese, Christopher N. Graham, Emma Hawe, Jean-Gabriel Le Moine (abstract)
e20038 - Current real-world treatment patterns and outcomes in patients with relapsed/refractory multiple myeloma
Jenny Willson, Amanda Bruno, Joanna Opalinska, Jeanenne Joy Nelson, Orsolya Lunacsek, Dana Stafkey-Mailey, Joanne P. Willey (abstract)
e20039 - Carfilzomib and cardiac events in a single institution non-Caucasian cohort
Ankit Mangla, Koosha Paydary, Jiaxiang Liu, Chimezie Mbachi, Romy Jose Thekkekara, Nikki Agarwal, Thomas E. Lad (abstract)
e20040 - Economic burden of early progression in newly-diagnosed multiple myeloma patients
Shivani Pandya, Zoe Clancy, Sulena Shrestha, Li Wang, Quanhong Ni, Onur Baser (abstract)
e20041 - Maintenance (MT) treatment (Tx) after lenalidomide, bortezomib, and dexamethasone (RVD) induction and stem cell transplant (SCT) in high-risk (HR) patients (pts) with newly diagnosed multiple myeloma (NDMM): A real-world analysis
Rafael Fonseca, Kejal Parikh, Brian Ung, Quanhong Ni, Amit Agarwal (abstract)
e20042 - Correlation between 24-hour urine protein and spot urine protein-to-creatinine ratio in multiple myeloma
Saad Jamshed, Jonathan Bress, Qiu Tong, Roberto Vargas (abstract)
e20046 - Self-reported adherence to lenalidomide as maintenance therpay for multiple myeloma after autologous stem cell transplantation
Ilana Schlam, Garima Gupta, James H. Essell (abstract)
